Search clinical trials for: VT-464: given orally once daily in 28 day cycles
Total 14 results
-
Innocrin PharmaceuticalCompletedCastration-resistant Prostate Cancer | CRPCUnited States
-
Innocrin PharmaceuticalNational Cancer Institute (NCI)Completed
-
Innocrin PharmaceuticalCompletedCastration-resistant Prostate Cancer | CRPCUnited States, Greece, Switzerland, United Kingdom
-
Tyra Biosciences, IncRecruitingSolid Tumor | Intrahepatic Cholangiocarcinoma | Metastatic Cholangiocarcinoma | Locally Advanced CholangiocarcinomaUnited States
-
Innocrin PharmaceuticalProstate Cancer Foundation; Prostate Cancer Clinical Trials ConsortiumCompleted
-
Yonsei UniversityUnknown
-
ViiV HealthcareCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States
-
Meirav Kedmi MDJohnson & JohnsonUnknownDiffuse Large B Cell Lymphoma | Recurrent Disease | Refractory Cancer | Primary Mediastinal (Thymic) Large B-cell Lymphoma | Transformed Indolent LymphomaIsrael
-
Ifakara Health InstituteUniversity of OxfordNot yet recruitingControlled Human Malaria Infection | Malaria Transmission | Induced Blood Stage Malaria Infection | Malaria ChallengeTanzania
-
Sun Yat-sen UniversityRecruitingTriple Negative Breast CancerChina
-
Azad University of Medical SciencesCompletedMucositis | Infection | Dry MouthIran, Islamic Republic of
-
Memorial Sloan Kettering Cancer CenterPfizer; Dana-Farber Cancer Institute; University of Pittsburgh; University of VirginiaCompletedNeurofibromatosis | Meningioma | CNS Cancer | Hemangioblastoma | Intracranial HemangiopericytomaUnited States
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted
-
M.D. Anderson Cancer CenterRecruitingRecurrent Adult Lymphoblastic Lymphoma | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Refractory T Acute Lymphoblastic Leukemia | Recurrent T Acute Lymphoblastic Leukemia | Refractory Lymphoblastic LymphomaUnited States